Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomised trial

This publication has 12 references indexed in Scilit:

• Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer.
  Journal of Clinical Oncology, 1995
• Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials.
  Journal of Clinical Oncology, 1993
• Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group.
  Journal of Clinical Oncology, 1991
• A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: interim report
  British Journal of Cancer, 1989
• Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Eastern cooperative oncology group study (EST 3275)
  Cancer, 1985
• Efficacy of prolonged intermittent therapy with combined 5-FU and methyl-CCNU following resection for gastric carcinoma. A veterans administration surgical oncology group report
  Cancer, 1983
• The general rules for the gastric cancer study in surgery and pathology
  Surgery Today, 1981
• Gastric carcinoma treated by chemotherapy after resection: A controlled study
  The American Journal of Surgery, 1980
• Factors related to survival following resection for gastric carcinoma.Analysis of 903 cases
  Cancer, 1977
• Use of Triethylenethiophosphoramide as an Adjuvant to the Surgical Treatment of Gastric and Colorectal Carcinoma
  Annals of Surgery, 1971